Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)

NCT00133250 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Abciximab
OTHER: Placebo Heparin Sodium

Sponsor

Deutsches Herzzentrum Muenchen

Collaborators

[object Object]